New Weight Loss Pill 2022

New weight loss pill to be approved by early 2026

Eli Lilly CEO expects new weight loss pill to be approved next year

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.

Becker's Hospital Review · 2d

New weight loss pill to be approved by early 2026: Eli Lilly

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13, according to a Wall Street Journal report.

MarketWatch on MSN · 2d

Eli Lilly’s stock falls as weight-loss drug sales disappoint

Shares of Eli Lilly and Co. slipped 0.4% in premarket trading Tuesday, after the drug maker provided a disappointing fourth-quarter revenue outlook, citing slower-than-expected growth in sales of its weight-loss drugs.

34m

Medicare announces 15 new drugs up for price negotiations, including Ozempic

The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, ...

Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Novo Nordisk says its high-dose semaglutide trial shows 20.7% weight loss

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

Ibj.com7d

Lilly sees new weight-loss pill approval in early 2026, CEO says

Indianapolis-based Eli Lilly and Co. is projecting approval of its experimental weight-loss pill as soon as early 2026, CEO Dave Ricks said, one of several in a new generation of the popular ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results